ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 8, August 2025 | pp. 733–739
DOI: 10.46882/AJIDR/148868
Article Type: Epidemiological Study
Title: Seroprevalence and risk factors of Strongyloides stercoralis hyperinfection risk among immunocompromised adults receiving corticosteroid therapy
Names of Authors: Grace Muthoni¹*, Henrik Weber²
Authors’ Affiliations: ¹Department of Internal Medicine, Kenyatta University, Nairobi, Kenya. ²Department of Tropical Medicine, University of Hamburg, Hamburg, Germany.
Abstract: Strongyloides stercoralis causes chronic autoinfective helminthiasis capable of progressing to fatal hyperinfection syndrome upon immunosuppressive therapy. We evaluated anti-Strongyloides seroprevalence and larval shedding among patients initiated on systemic corticosteroids or chemotherapy. Serum and stool samples from 270 immunocompromised adults were tested via recombinant NIE enzyme-linked immunosorbent assay and Baermann concentration technique. Seropositivity reached 24.1 percent, with active rhabditiform larvae detected in 8.9 percent of stool specimens. Barefoot farming and eosinophilia independently predicted infection. Routine pre-immunosuppression screening and empirical ivermectin prophylaxis are strongly recommended.
Keywords: Strongyloides stercoralis, Hyperinfection syndrome, Immunosuppression, Ivermectin, Neglected tropical diseases
Citation: Muthoni G, Weber H (2025). Seroprevalence and risk factors of Strongyloides stercoralis hyperinfection risk among immunocompromised adults receiving corticosteroid therapy. African Journal of Infectious Diseases Research, 12(8): 733–739. DOI: 10.46882/AJIDR/148868
Manuscript Timeline: Received: July 07, 2025; Revised: August 07, 2025; Accepted: August 18, 2025; Published: August 25, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read